Diabetes

The Pharmacy Times® Diabetes resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

What can we help you find?

Lilly Set to Launch Lower Cost Humalog Insulin Options in April

Lower-priced versions of Humalog Mix75/25 KwikPen and Humalog Junior KwikPen will be available in mid-April and will have 50% lower list prices compared with branded versions.

FDA Approves Insulin Aspart Injection for Children with Diabetes

The treatment is the first and only fast-acting mealtime insulin injection that does not have a pre-meal dosing recommendation, according to Novo Nordisk.

Study Compares 2-Dose Versus 3-Dose Hepatitis B Vaccine in Older Patients With Type 2 Diabetes

The immunogenicity and safety of hepatitis B surface antigen (HBsAg)/CpG 1018 was assessed in patients with diabetes aged 60 to 70 years.

Dapagliflozin Reduces Risk of Mortality, Heart Failure Events Regardless of Type 2 Diabetes Status

Results of the DAPA-HF trial demonstrate the efficacy and safety of dapagliflozin in patients with heart failure.

Immunizing Those With Diabetes Requires Special Considerations

Rates of some vaccinations are low in these patients, but pharmacists can play a key role in adherence.

FDA Vows to Uphold Drug Quality Standards in Response to Recent Impurity Concerns

According to Janet Woodcock, MD and director of FDA’s Center for Drug Evaluation and Research, the agency is focused on the drugs used by Americans continuing to meet “strict quality standards.”

Dapagliflozin: Benefits in Heart Failure Patients With and Without Diabetes

A new study has found that patients with heart failure with reduced ejection fraction receiving dapagliflozin decreased their risk of worsening HF or death from cardiovascular events.

FDA Approves Insulin Glargine Injection for Pediatric Patients with Diabetes

The approval was based on a phase 3 EDITION JUNIOR trial evaluating children and adolescents, aged 6 to 17 years, living with type 1 diabetes.

Eye Health Is Key in Diabetes Management

Ocular conditions can lead to serious complications, and sometimes there are no early symptoms.

FDA Approves Generic Metformin Hydrochloride Extended-Release Tablets

Metformin hydrochloride extended-release tablets are indicated to for improving glycemic control in patients with type 2 diabetes mellitus, as an adjunct to diet and exercise.

Digital Interventions Benefit Patients with Diabetes

Clinical data has illustrated how digital interventions can have a substantial material benefit on glycemic control in users with diabetes, with 73 of 162 users in the study reducing their average blood glucose levels to under 140 mg/dL.

AstraZeneca Launches Diabetes Can Break Your Heart Campaign for World Diabetes Day

In honor of World Diabetes Day, AstraZeneca has launched the campaign Diabetes Can Break Your Heart, the national movement aimed to change the trajectory of heart failure in type 2 diabetes.

The Pharmacy Times® Diabetes specialty page serves as a hub for all clinical news and articles related to the condition. The coverage includes best practices for treating diabetes, from the early signs and symptoms like increased thirst, fatigue, and blurred vision; and addresses the primary causes of diabetes – the destruction of insulin-producing beta cells of the pancreas.

The Pharmacy Times® Diabetes condition center provides a source of all the latest clinical information, with articles covering updates from the robust pipeline of novel diabetes therapies, and the newest data from all phases of clinical trials and studies in the space.